Skip to content

Released Aug 3, 2017, after the close

10-Q filed Aug 3, 2017, 34 days after period end · 0001558370-17-005864

Q2 2017 · 10-Q
Revenue$65.08M+19.7% vs Q2 2016+24.7% vs Q1 2017
Net Income-$44.22MN/M vs Q2 2016N/M vs Q1 2017
EPS Diluted-$0.30N/M vs Q2 2016N/M vs Q1 2017
Operating Income-$41,011,000N/M
Operating Cash Flowderived-$32,451,000N/M
Free Cash Flowderived-$33,160,000N/M
Margins · derived
Operating margin-63.0%−34.8 pt vs Q2 2016
Net margin-68.0%−28.0 pt vs Q2 2016

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2017Q2 2016Q2 2015Q2 2014
Revenue$65.08M$54.35M$27.74M$6.84M
Net Income-$44.22M-$21.70M——
EPS Diluted-$0.30-$0.15-$0.34-$0.44

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR